| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.08 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.08 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.08 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.09 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.09 | 0.09 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.083 | 0.09 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.09 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.19 | 0.09 |